ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

NIAMDD Scientists Find Virus Gene Causes, Continues Cancer

May 9, 1975

In Brief: Illinois Legislature Votes Nearly $1 Million To ICC; Carolyne Davis Resigns From HCFA Jobs

August 2, 1985

In Brief: Smyth Moves From AOR To Bristol-Myers; Lurie Center Wins Grants From Army, NCI

December 13, 1996

Colon Cancer Screening Interval 5-10 Years Suggested

September 26, 2008

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004